eliya.farah [at] mail.mcgill.ca (Email Eliya)
Eliya received his BSc in Biology and Math from the University of Ottawa in 2019. Throughout this time, he worked as a research assistant at the Faculty of Medicine in the field of Nanomedicine and Neurodegenerative diseases. This increased his passion in research and led him to the Public health sector where he decided to join McGill for a Master’s in Public Health & Epidemiology.
Click here to view Eliya's publications.
CURRENT POSITION
MSc. Public Health & Epidemiology Student
CURRENT PROJECT
A pandemic that originated in Wuhan, China in 2019 is now the spotlight of major medicinal and research efforts in almost every country in the world. SARS-CoV-2 is a serious health threat to everyone and it is clear that the pandemic has produced enough severe illness to overwhelm the healthcare infrastructure around the globe. Consequently, governments around the world are re-allocating medical resources, delaying treatment, and postponing screening for a range of other serious diseases. These preventive measures taken in response to the COVID-19 pandemic have adversely affected an entire range of activities. More specifically, activities related to cancer control, prevention, and care. As the pandemic progresses, cancer diagnoses are getting delayed, and the onset of treatment is deferred to a later date for most cancer patients. Governments and policymakers must do all they can to prevent the scarcity of medical resources, especially when dealing with a disease like cancer, which is the second leading cause of death globally. The objective of my project is to conduct an in-depth systematic review of the emerging scientific and policy literature on the impact that the COVID-19 pandemic has been causing on the quality of 1) Cancer control, which involves cancer screening and prevention 2) Cancer care in general which includes various cancer treatments.